Algert Global’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.41M Sell
361,280
-66,610
-16% -$1.05M 0.08% 433
2026
Q1
$6.14M Sell
427,890
-49,108
-10% -$815K 0.09% 377
2025
Q4
$8.41M Buy
476,998
+234,698
+97% +$3.88M 0.13% 264
2025
Q3
$3.81M Buy
+242,300
New +$3.4M 0.06% 490
2024
Q3
Sell
-14,227
Closed -$169K 1542
2024
Q2
$169K Buy
+14,227
New +$162K 0.01% 1314
2023
Q1
Sell
-80,125
Closed -$667K 1289
2022
Q4
$667K Buy
+80,125
New +$598K 0.04% 717

Other funds holding SHC

Algert Global's SHC Position: Q2 2026 in Review

Algert Global reduced its Sotera Health (SHC) stake by 16% in Q2 2026, selling an estimated $1.05M and leaving 361,280 shares worth $6.41M. The position accounts for 0.08% of the portfolio, ranked #433.

Algert Global first reported a position in SHC in Q4 2022 and has held it in 6 quarters since. The position peaked at $8.41M in Q4 2025. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Algert Global held 361,280 shares of Sotera Health worth $6.41M as of Q2 2026.
  • Algert Global sold 66,610 Sotera Health shares in Q2 2026, an estimated $1.05M.
  • Sotera Health made up 0.08% of Algert Global's portfolio in Q2 2026, its #433 holding.
  • Algert Global first reported a position in Sotera Health in Q4 2022 and has held it in 6 quarters since.
  • Algert Global's Sotera Health position peaked at $8.41M in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.